![Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B | Scientific Reports Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22699-8/MediaObjects/41598_2022_22699_Fig1_HTML.png)
Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B | Scientific Reports
MedSchool - Serological markers are useful for assessing for active or past hepatitis B infection. Hepatitis B surface antigen (HbsAg) is indicative of active hepatitis B infection. This test does not distinguish
![Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B](https://f6publishing.blob.core.windows.net/10f0376a-eac6-401d-92d1-348e70c8a0e2/WJG-27-6927-g004.png)
Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
![Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/rr/social-media/rr7201a1_HepatitisB_IMAGE_10Mar2023_1200x675-v2-medium.jpg?_=10974)
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR
![Frontiers | Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure Frontiers | Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure](https://www.frontiersin.org/files/Articles/972687/fmicb-13-972687-HTML/image_m/fmicb-13-972687-g001.jpg)